[On the question of the role of guanidine groups of dihydrostreptomycin molecules in the manifestation of biological activity and neurotoxic action].
D000818:Animals; D004096:Dihydrostreptomycin Sulfate / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D006146:Guanidines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D066298:In Vitro Techniques; D051379:Mice; D011511:Proteus / Q000187:drug effects; D012485:Salmonella typhi / Q000187:drug effects; D012760:Shigella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014508:Urea / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D000159:Vestibulocochlear Nerve / Q000187:drug effects*
D006146:Guanidines; D014508:Urea; D004096:Dihydrostreptomycin Sulfate
K voprosu o roli guanidinovykh grupp molekuly digidrostreptomitsina v proiavlenii biologicheskoĭ aktivnosti i neĭrotoksicheskogo deĭstviia.